Viewing Study NCT00929968


Ignite Creation Date: 2025-12-24 @ 5:44 PM
Ignite Modification Date: 2025-12-27 @ 7:03 PM
Study NCT ID: NCT00929968
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2009-06-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability and Pharmacokinetics of Multiple Doses of VAK694 in Atopic Subjects With Seasonal Rhinitis
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module